Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

The peritoneum is a common site of dissemination for colorrectal cancer, with a poorer
prognosis than other sites of metastases. In the last two decades, it has been considered as …

Background The addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to
cytoreductive surgery has been associated with encouraging survival results in some …

Colorectal cancer (CRC) is one of the most common malignancies in Western countries.
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …

Aim Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an experimental drug
delivery method that applies chemotherapy into the abdominal cavity as an aerosol under …

Abstract Background The French PRODIGE 7 trial, published on January 2021, has raised
doubts about the specific survival benefit provided by HIPEC with oxaliplatin 460 mg/m2 (30 …

Importance The peritoneal surface is a common site of disease in ovarian and colorectal
cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic efforts …

Objectives The therapeutic efficacy of cytoreductive surgery (CRS) plus hyperthermic
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …

The purpose of the present review was to describe evidence-based indications for
hyperthermic intraperitoneal chemotherapy (HIPEC), with cytoreductive surgery (CRS), in …

Background Patients with peritoneal metastases from colorectal cancer have a poor
prognosis. If the intraperitoneal tumour load is limited, patients may be eligible for …